2.59
4.78%
-0.13
Gelteq Ltd Borsa (GELS) Ultime notizie
The Benchmark Company Announces Upcoming Discovery One-on-One Investor Conference - The Manila Times
Why Credo Technology Group Shares Are Trading Higher By 40%; Here Are 20 Stocks Moving Premarket - Inkl
Oral drug and nutrient gel specialist soars after top client bumps up order by 50% - Mugglehead
NovoCure Limited (NASDAQ: NVCR): Groundbreaking PANOVA-3 Trial Results Signal Hope for Pancreatic Cancer Patients - BP Journal
Gelteq Limited (NASDAQ: GELS): Transforming Nutraceuticals with Gel-Based Innovation and Strategic U.S. Expansion - BP Journal
The Ascending Trajectory of Purple Biotech Ltd (PPBT): Pioneering Pancreatic Cancer Treatment with CM24 - BP Journal
Senti Biosciences, Inc. (SNTI) could keep surging and here’s why - BP Journal
Stock market news: Senti Biosciences +404.62%, Fossil Group +54.11% among top gainers during mid day trading - Business Upturn
Polyrizon Ltd.’s Quiet Period To End on December 9th (NASDAQ:PLRZ) - Defense World
Gelteq Limited’s (NASDAQ:GELS) Quiet Period To End on December 9th - Defense World
Gelteq (GELS) Ramps Up Production: 400,000 Gel Units Set for Global Distribution | GELS Stock News - StockTitan
Gelteq Limited Appoints Adam Bendell as President of U.S. Operations - Marketscreener.com
Med-tech funding rises, driven by private investments and follow-ons - BioWorld Online
Gelteq Closes $5.2M IPO By Investing.com - Investing.com Australia
Gelteq launches IPO, raises $5.2 million for expansion - Investing.com India
Gelteq Limited Closes US$5.2 Million Initial Public Offering - The Manila Times
GELSGelteq Limited Ordinary Shares Latest Stock News & Market Updates - StockTitan
Gelteq Closes $5.2M IPO - Investing.com
Argent Biopharma Lists New Shares on ASX - MSN
Biotech company Gelteq prices IPO at $4 per share - MSN
Vietnam Manufacturing & Export Processing to Announce Quarterly Results - MSN
Maas Group Reports Record Results and Growth Strategy - MSN
Qualitas Limited Releases 2024 Governance Statement - MSN
Biotech company Gelteq prices IPO at $4 per share (NASDAQ:GELS) - Seeking Alpha
WiseTech Investor Urges Progress, Transparency Amid CEO Scandal - MSN
Novatti Group Announces Hybrid Annual General Meeting - MSN
Gelteq Limited Prices US$5.2 Million Initial Public Offering - The Manila Times
RooLife Group Announces AGM with Key Resolutions - MSN
Ingram Micro IPO: Major tech product distributor debuts on NYSE today after pricing its stock within target range - MSN
Strike Resources Limited Announces Upcoming AGM Details - MSN
IPO Roundup: Ingram Micro Holdings, Peak Resources and more (NYSEARCA:IPO) - Seeking Alpha
Nathan Givoni & Simon Szewach on Gelteq - The Good Men Project
Aldebaran Financial Inc. Purchases 710 Shares of Invesco QQQ (NASDAQ:QQQ) - Defense World
SkyView Investment Advisors LLC Boosts Stock Holdings in General Electric (NYSE:GE) - Defense World
Mira Pharmaceuticals (NASDAQ:MIRA) Stock Quotes, Forecast and News Summary - Benzinga
Redhill Biopharma (NASDAQ:RDHL) Stock Quotes, Forecast and News Summary - Benzinga
Diabetes Assays Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies - GlobalData
AST SpaceMobile registers shares in Antares reorg - MSN
AN2 Therapeutics (NASDAQ:ANTX) Stock Quotes, Forecast and News Summary - Benzinga
Cingulate (NASDAQ:CING) Stock Quotes, Forecast and News Summary - Benzinga
Reviva Pharmaceuticals (NASDAQ:RVPH) Stock Quotes, Forecast and News Summary - Benzinga
Athira Pharma (NASDAQ:ATHA) Stock Quotes, Forecast and News Summary - Benzinga
Verrica Pharmaceuticals (NASDAQ:VRCA) Stock Quotes, Forecast and News Summary - Benzinga
Marinus Pharma (NASDAQ:MRNS) Stock Quotes, Forecast and News Summary - Benzinga
IGC Pharma (AMEX:IGC) Stock Quotes, Forecast and News Summary - Benzinga
Free Stock Market Newsletter | MarketBeat Daily Ratings - MarketBeat
ADVFNFree stock and cryptocurrency prices, charts, market news and streaming real-time quotes. - ADVFN
InvestorsHubNYSE, NASDAQ, AMEX, OTCBB, Pink Sheet Stock Message Boards, Stock Charts, Stock Quotes, Level II and Market News - InvestorsHub
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):